Clinical Scorecard: Broadening the Phenotypic Range of Xq28 Duplications Involving MECP2: A Case Study from a Family

At a Glance

Key Highlights

• Xq28 duplication syndrome is associated with severe neurodevelopmental impairments, especially in males.
• Clinical manifestations vary significantly between affected males and females due to X-chromosome inactivation.
• The condition involves multiple genes, including MECP2, SLC6A8, and L1CAM, contributing to phenotypic variability.
• Family history may reveal additional affected male relatives with similar or more severe presentations.
• Advances in molecular diagnostics have improved identification of this condition.

Guideline-Based Recommendations

Diagnosis

• Consider Xq28 duplication in the differential diagnosis of families with X-linked intellectual disability.
• Utilize array comparative genomic hybridization (array-CGH) and high-resolution chromosome microarrays for diagnosis.

Management

• Provide supportive care and early intervention for developmental delays.
• Monitor for associated neurological issues such as epilepsy and behavioral problems.

Monitoring & Follow-up

• Regular assessments of cognitive and motor development.
• Evaluate for potential comorbidities, including spasticity and recurrent infections.

Risks

• Increased risk of severe intellectual disability and associated neurological impairments.
• Potential for variable expression of symptoms in female carriers.

Patient & Prescribing Data

Affected individuals from families with confirmed Xq28 duplications.

Management focuses on supportive therapies, including speech and occupational therapy, tailored to individual needs.

Clinical Best Practices

• Conduct comprehensive clinical assessments using standardized diagnostic algorithms.
• Engage in genealogical analysis to identify affected family members.
• Ensure informed consent is obtained for genetic testing and participation in research.

References

• Xq28 duplication syndrome literature